SciGeneX
SciGeneX
  • HOME
  • ABOUT US
    • OUR STORY
    • OUR TEAM
    • OUR VISION & VALUES
    • CIRCULAR ECONOMY
    • OUR KEY PARTNERS
  • PRODUCTS
    • NATIVE ANTIGENS
    • BIO-SPECIMENS
    • ANTIBODIES & CONJUGATES
    • MEDICAL DEVICES
    • PHARMACEUTICALS
  • CDMO
    • DRUG DISCOVERY
    • PHARMACOLOGY
    • BIOLOGICS DEVELOPMENT
    • PEPTIDES DEVELOPMENT
    • FORMULATION DEVELOPMENT
    • BUSINESS CONSULTANCY
  • INVESTORS
  • CONTACT US
  • More
    • HOME
    • ABOUT US
      • OUR STORY
      • OUR TEAM
      • OUR VISION & VALUES
      • CIRCULAR ECONOMY
      • OUR KEY PARTNERS
    • PRODUCTS
      • NATIVE ANTIGENS
      • BIO-SPECIMENS
      • ANTIBODIES & CONJUGATES
      • MEDICAL DEVICES
      • PHARMACEUTICALS
    • CDMO
      • DRUG DISCOVERY
      • PHARMACOLOGY
      • BIOLOGICS DEVELOPMENT
      • PEPTIDES DEVELOPMENT
      • FORMULATION DEVELOPMENT
      • BUSINESS CONSULTANCY
    • INVESTORS
    • CONTACT US
  • HOME
  • ABOUT US
    • OUR STORY
    • OUR TEAM
    • OUR VISION & VALUES
    • CIRCULAR ECONOMY
    • OUR KEY PARTNERS
  • PRODUCTS
    • NATIVE ANTIGENS
    • BIO-SPECIMENS
    • ANTIBODIES & CONJUGATES
    • MEDICAL DEVICES
    • PHARMACEUTICALS
  • CDMO
    • DRUG DISCOVERY
    • PHARMACOLOGY
    • BIOLOGICS DEVELOPMENT
    • PEPTIDES DEVELOPMENT
    • FORMULATION DEVELOPMENT
    • BUSINESS CONSULTANCY
  • INVESTORS
  • CONTACT US

BIOLOGICS DEVELOPMENT

Cell Lines Development

We provide advanced technology platforms optimized for high-expression cell line development, enabling high-cell-density production of monoclonal antibodies, antibody fragments, proteins, peptides, and vaccine candidates. We are also equipped to develop complex molecules like Biosimilars addressing the molecular complexities of physicochemical and biological attributes.  


We have following technology platforms for high expression with desired quality:

  • CHO Cell Platform
  • E Coli Platform
  • Yeast Platforms
  • Sp2/o Platform
  • HEK Cell Platform 

Bio-Process Development

Our Technology Platforms support the process development and pre-clinical manufacturing of monoclonal antibodies, antibody fragments, proteins, peptides and ADCs on the different Technology Platforms:

  • High Cell Density Mammalian Platform
  • High Cell Density Microbial Platform
  • High Cell Density Yeast Platform

Analytical Characterization

We offer high order physiocochemical and biological  characterization of proteins, antibodies and peptides.

Copyright © 2025 SciGeneX - All Rights Reserved.

  • HOME

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept